Recruiting
Phase 2

Local Ablative Therapy

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05429320

Conditions

Non-small Cell Lung Cancer

Metastatic Non Small Cell Lung Cancer

Nsclc

NSCLC Stage IV

Minimal Residual Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Local ablative therapy

Blood collection to assess for ctDNA

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2024-08-15.